isabelobrien, Author at European Medical Journal - Page 42 of 66

Say hello to EMJ GOLD!

Join us for the next chapter of GOLD as we launch on our new home here on the EMJ website, providing you with a one-stop-shop for all your healthcare content needs.

Spotlight: February 2024

GOLD looks back on some of the top pharma news stories from the past month, including new approvals, the latest appointments and departures in the industry and more.

HBA announces 2024 Woman of the Year

Alnylam’s Dr Yvonne Greenstreet is named Woman of the Year by the Healthcare Businesswomen’s Association

Spotlight: December 2023

Take a look at the top pharma news stories of the past month including projections for the years ahead, new investments, pricing negotiations and more.

Spoonful of technology: Oct-Dec 2023

Dive into the top technology stories of the past few months as GOLD explores the funding landscape and the latest innovations in the health tech market

Get ready for Gen Z doctors

A new generation of doctors is making their way into the workforce, but is the pharmaceutical industry ready to change its tactics to engage these younger HCPs?

Has medical affairs reached 'strategic pillar' standing?

The value of medical affairs is not up for debate, but are companies allocating enough time and resources to make it the strategic function it can be?

VPAG: the UK's ticket to pharma superpower status?

A deal ends months of wrangling between the UK government and the ABPI, but what will it mean for the industry and the UK’s bid to become a life sciences superpower?

Haematology under the microscope

This infographic explores the vastness of the haematology market, including key industry players, drugs to watch, the global burden of haematological diseases and more.

Cardiology under the microscope

This infographic explores the ins and outs of the cardiology market, including market size, top pharmaceutical and medical device players and the regional impact of cardiovascular disease.